clinical trial · NCT07820930
A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Mapping in Patients Undergoing Repeat Ablation for Atrial Fibrillation
Atrial Fibrillation (AF)Persistent Atrial Fibrillation (PersAF)Paroxysmal Atrial Fibrillation (PAF)FARAFLEX Mapping and Pulsed Field Ablation System
brief summary
The goal of the ReDEFINE-AF Clinical Study is to evaluate the safety and effectiveness of the FARAFLEX™ Mapping and Pulsed Field Ablation System with electrographic flow mapping in subjects undergoing repeat ablation for atrial fibrillation (AF).
started
Nov 1, 2026
primary completion
Jul 1, 2029
completion
Jul 1, 2031
last updated
Sep 28, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol